Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Pôle Des Pathologies Digestives, Hépatiques Et de La Transplantation, Hôpital de Hautepierre-Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, France 1, Avenue Moliere, 67098, Strasbourg, France.
ICube, Université de Strasbourg, CNRS UMR 7357, Illkirch, France.
J Gastrointest Surg. 2023 Jun;27(6):1141-1151. doi: 10.1007/s11605-023-05633-9. Epub 2023 Mar 1.
The best surgical approach to treat synchronous colorectal liver metastases (CRLM) remains unclear. Here, we aimed to identify prognostic factors associated with limited survival comparing patients undergoing primary-first resection (PF) and simultaneous resection (SR) approaches.
We retrospectively reviewed clinical data of 217 patients who underwent resection for synchronous CRLMs between January 1, 2011, and December 31, 2021. There were 133 (61.2%) PF resection and 84 (38.8%) SRS. The two groups of patients were compared using propensity score matching (PSM) analysis and cox analysis was performed to identify prognostic factors for overall survival (OS).
After PSM, two groups of 71 patients were compared. Patients undergoing SR had longer operative time (324 ± 104 min vs 250 ± 101 min; p < 0.0001), similar transfusion (33.3% vs 28.1%; p = 0.57), and similar complication rates (35.9% vs 27.2%; p = 0.34) than patients undergoing PF. The median overall survival and 5-year survival rates were comparable (p = 0.94) between patients undergoing PF (48.2 months and 44%) and patients undergoing SR (45.9 months and 30%). Multivariate Cox analysis identified pre-resection elevated CEA levels (HR: 2.38; 95% CI: 1.20-4.70; P = .01), left colonic tumors (HR: 0.34; 95% CI: 0.17-0.68; P = .002), and adjuvant treatment (HR: 0.43; 95% CI: 0.22-0.83; P = .01) as independent prognostic factors for OS.
In the presence of synchronous CRLM, right colonic tumors, persistent high CEA levels before surgery, and the absence of adjuvant treatment identified patients characterized by a limited survival rate after resection. The approach used (PF vs SR) does not influence short and long-term outcomes.
治疗同步结直肠肝转移(CRLM)的最佳手术方法仍不清楚。在这里,我们旨在确定与接受初次手术切除(PF)和同时切除(SR)的患者有限生存相关的预后因素。
我们回顾性分析了 2011 年 1 月 1 日至 2021 年 12 月 31 日期间接受同步 CRLM 切除术的 217 例患者的临床资料。其中 PF 切除 133 例(61.2%),SR 切除 84 例(38.8%)。采用倾向评分匹配(PSM)分析比较两组患者,采用 Cox 分析确定总生存(OS)的预后因素。
PSM 后,比较了两组 71 例患者。SR 组患者的手术时间更长(324±104 分钟比 250±101 分钟;p<0.0001),输血相似(33.3%比 28.1%;p=0.57),并发症发生率相似(35.9%比 27.2%;p=0.34)。PF 组患者的中位总生存时间和 5 年生存率与 SR 组患者相当(p=0.94),分别为 48.2 个月和 44%,45.9 个月和 30%。多变量 Cox 分析确定术前升高的 CEA 水平(HR:2.38;95%CI:1.20-4.70;P=0.01)、左半结肠癌(HR:0.34;95%CI:0.17-0.68;P=0.002)和辅助治疗(HR:0.43;95%CI:0.22-0.83;P=0.01)是 OS 的独立预后因素。
在存在同步 CRLM 的情况下,右半结肠癌、术前持续高 CEA 水平和缺乏辅助治疗可识别出术后生存时间有限的患者。所采用的方法(PF 与 SR)不影响短期和长期结果。